HA HASI Q1 2026 Beat Revenue NA EPS Exceeds by Significant Ingredion Incorporated INGR Steady at 10262 Awaiting Next Catalyst 20260515 Hesai HSAI Q4 2025 Results Fall Short EPS 111 Revenue NA X Commits to Faster Removal of Hate and Terror Content in UK Amid Regulatory Pressure XBiotech Inc XBIT Edges Higher on Modest Volume Tests Resistance Near 258 PIMCO Dynamic Income Strategy Fund PDX Edges Lower Amidst Consolidation Miami International Holdings MIAX Edges Higher Testing Key Resistance Levels LB Pharmaceuticals Inc LBRX Breaks Higher as Volume Picks Up Key Resistance Ahead